Nut and Peanut Hypersensitivity: Clinical Trials

4 trials for Nut and Peanut Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Terminated 4
Phase 24Terminated 4

Follow Nut and Peanut Hypersensitivity: new trials by email Literature Review of Nut and Peanut Hypersensitivity trials Research Report on Nut and Peanut Hypersensitivity

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Extension Study of ADP101
ADP101 - Food Allergy
Phase 1 / Phase 2TerminatedAlladapt Immunotherapeutics, Inc.452022-03-142024-03-26
Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
Peanut Immunotherapy - Food Allergy, Peanut Allergy
Phase 1 / Phase 2TerminatedUniversity Hospital, Geneva122019-04-012023-08-28
The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
Peanut Dissolving Film - Peanut Allergy
Phase 1 / Phase 2TerminatedJohns Hopkins University52012-11-012018-07-03
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
Peanut flour - Peanut Allergy
Phase 1 / Phase 2TerminatedUniversity of North Carolina, Chapel Hill52010-12-012018-03-27

Narrower conditions

Peanut Hypersensitivity (4)  ·  Food Hypersensitivity (3)  ·  Egg Hypersensitivity (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Milk Hypersensitivity (1)  ·  Nut Hypersensitivity (1)  ·  Shellfish Hypersensitivity (1)  ·  Wheat Hypersensitivity (1)

Broader conditions

Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Food Hypersensitivity (1)

Sponsors

Alladapt Immunotherapeutics, Inc. (1)  ·  Johns Hopkins University (1)  ·  University Hospital, Geneva (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Corinne Keet, MD, MS (1)  ·  Hugh Sampson, MD (1)  ·  Jean-Christoph Caubet, MD (1)  ·  Mei-Lun Wang, MD (1)  ·  Robert Wood, MD (1)  ·  Wesley Burks, MD (1)

NIH funding

2018 (1)